Executive readout · one minute
Call research workspace
Read the call alongside every captured source. 8-K earnings release, 10-Q stay in one workspace.
RGNX
$7.53
+1.07%
RGNX
· REGENXBIO Inc.
$7.53
+0.08 (+1.07%)
At close · Sep 30
Return incl. dividend (before tax)
Going-concern doubt
— cleared Aug 6, 2026
The latest filing no longer states the doubt (first flagged May 14, 2026).
View the 10-Q filed Aug 6, 2026Market Cap
$488.50M
Shares
66.01M
Volume · Sep 30
1.79M
Avg daily vol (3M)
1.66M
All earnings calls
Earnings call · FY2025 Q2
REGENXBIO Inc. (RGNX) Q2 2025 Earnings Call
Research coverage
2 live sources
Open each available source without leaving this research workspace.
Revenue
$21.36M
-4.2% YoY
Diluted EPS
-$1.38
Net income
-$70.87M
Research materials
Open the source you need; every reader stays inside this workspace.
Quarter detail
How the reported period landed and where the business moved.
SEC filing · Item 2.02
8-K earnings release
Filed Aug 7, 2025 · complete as-filed document
SEC periodic report
10-Q report
Filed Aug 7, 2025 · complete as-filed document